Susan Kalled - Feb 17, 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Chief Scientific Officer
Signature
/s/ Susan Kalled
Stock symbol
CMPX
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/18/2022, 05:55 PM
Next filing
Feb 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +60K $0.00 60K Feb 17, 2022 Common Stock 60K $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest over 48 substantially equal monthly installments starting 03/17/2022